Press release from Companies
Published: 2020-05-13 08:14:55
STENOCARE A/S ("STENOCARE") has been approved for listing on Nasdaq First North Growth Market Denmark. The company hereby announce that the first day of trading will be on 18 May 2020 under the symbol "STENO". The company will be delisted from Spotlight Stock Market and the last day of trading will be on 15 May 2020.
Certified Adviser at the time of listing
STENOCARE’s Certified Adviser will be Keswick Global AG, Reg. FN 332389 h, Hoffingergasse 16/1/6, 1120 Vienna, Austria, telephone number +43 (1) 533 88 90 0.
Danish Law
STENOCARE is a Danish company operating under Danish law, including the Danish Companies Act (Selskabsloven) and the Capital Markets Act (Kapitalmarkedsloven). Once the Company’s shares cease to be traded on Spotlight Stock Market, the Company will no longer be subject Swedish securities legislation.
For additional information regarding STENOCARE, please contact:
Thomas Skovlund Schnegelsberg, CEO
Phone: +45 31770060
E-mail: presse@stenocare.com
About STENOCARE A/S
STENOCARE A/S was founded in 2017 with the purpose of being an active participant in the Danish medical cannabis pilot program. The company was first to receive the Danish Medicines Agency's permission to import, distribute as well as cultivate and produce medical cannabis. The company offers medical cannabis oil that complies with the strict Danish regulatory requirements. STENOCARE is building a state-of-the-art production facility for the cultivation and production of medical cannabis at the company’s premises in Jutland, Denmark.
